Clinical Trials Browser

INDUSTRY × Interventional × Locally Advanced Gastric Cancer × Clear all

NCT05141747 2022-02-23

A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.

Phase 2 Unknown

Gastrointestinal

Locally Advanced Gastric Cancer